Skip to main content
. 2023 Aug 1;2023(8):CD007315. doi: 10.1002/14651858.CD007315.pub3
Study ID Intervention(s) and comparator(s) Participants included in analysis
(N) Participants discontinuing trial due to an adverse event
(N) Participants discontinuing trial due to an adverse event
(%)
Duncan 2018 I: hyperinsulinaemic normoglycaemia 226* 0* 0*
C: standard therapy 249* 0* 0*
Wallia 2017 I: intensive 23* 0* 0*
C: moderate 26* 0* 0*
Wahby 2016 I: tight glycaemic control 67 0 0
C: conventional moderate glycaemic control 68 0 0
Parekh 2016 I: moderately intense control 30 0 0
C: standard glucose control 30 0 0
Yuan 2015 I: intensive glycaemic management 106 0 0
C: conventional glycaemic management 106 0 0
Umpierrez 2015 I: intensive group 77* 0* 0*
C: conservative control 75* 0* 0*
Abdelmalak 2013 I: intensive glucose management 54* 0* 0*
C: conventional glucose management 49* 0* 0*
Hermayer 2012 I: intensive glycaemic control 44
C: standard glycaemic control 49
Desai 2012 I: strict blood glucose control 37*
C: liberal blood glucose control 44*
Lazar 2011 I: aggressive glucose control 40 0 0
C: moderate glucose control 42 0 0
Cao 2010 I: intensive insulin therapy 92
C: conventional insulin therapy 87
Glucontrol 2009 I: intensive insulin treatment 55*
C: intermediate glucose control 69*
NICE SUGAR 2009 I: intensive insulin therapy 3054a 304a 10a
C: conventional insulin therapy 3050a 225a 7.4a
Subramaniam 2009 I: continuous insulin infusion 62* 0* 0*
C: standard intermittent sliding‐scale insulin bolus 64* 0* 0*
Chan 2009 I: intensive insulin therapy 55a 7a 12.7a
C: conventional insulin therapy 54a 4a 7.4a
De La Rosa 2008 I: intensive insulin therapy 254a 0a 0a
C: conventional insulin therapy 250a 0a 0a
Gandhi 2007 I: intensive insulin therapy 37 0 0
C: conventional insulin therapy 36 0 0
Li 2006 I: continuous insulin infusion 51
C: glucometer‐guided insulin 42
Lazar 2004 I: tight glycaemic control with GIK 72 0 0
C: standard therapy 69 0 0
Rassias 1999 I: aggressive insulin therapy 13 0 0
C: standard insulin therapy 13 0 0
—: denotes not reported
adata from total study population.
*data provided by study authors (patients with diabetes).
C: comparator; I: intervention; GIK: glucose‐insulin‐potassium.